CDKN2C and head and neck squamous cell carcinoma: Differentially expressed CDKN2C was also detected in 13 cancer cell lines, namely CESC (cervical squamous cell carcinoma and endocervical adenocarcinoma), CHOL, COAD, ESCA, HNSCC, KIRC, LIHC, pancreatic adenocarcinoma, PRAD, SCLC, STAD, THCA, and UCS (uterine carcinosarcoma) (Fig. 5B).